Denise Caplena, Ph.D., Pmp
About Denise Caplena, Ph.D., Pmp
Denise Caplena, Ph.D., PMP, is the Associate Director, Planning and Execution Lead for Global Biometrics and Data Sciences at Bristol-Myers Squibb in the Greater New York City Area. She has over 15 years of experience in the biopharmaceutical industry and holds a Ph.D. in Biochemistry from the Georgia Institute of Technology.
Title and Role at Bristol-Myers Squibb
Denise Caplena, Ph.D., PMP, currently serves as Associate Director, Planning and Execution Lead, in the Global Biometrics and Data Sciences division at Bristol-Myers Squibb. Based in the Greater New York City Area, she is responsible for overseeing the planning and execution of data-driven initiatives, particularly in the realm of global clinical trials.
Previous Experience in the Biopharmaceutical Industry
Denise Caplena has accumulated over 15 years of experience in the biopharmaceutical industry. She served as a Program Manager at CONRAD from 2014 to 2018, and as a Scientist & CMC PM at Emergent BioSolutions from 2011 to 2014. Before that, she worked at Meridian Bioscience Inc. as a Protein Chemist & Project Lead for a year and at Cytovance Biologics as a Process Development Scientist & Acting PM from 2008 to 2010.
Educational Background
Denise Caplena holds a Ph.D. in Biochemistry from Georgia Institute of Technology, which she earned between 2002 and 2007. She also holds a BE in Polymer Science and Engineering from Shanghai Jiao Tong University, obtained between 1998 and 2002. In addition, she studied Advanced Project Management at Stanford University.
Professional Certifications
Denise Caplena is a certified Project Management Professional (PMP), which complements her role as a leading figure in planning and execution within the biopharmaceutical sector. This certification signifies her expertise and commitment to best practices in project management.
Contributions to Biopharmaceutical Research
Denise Caplena has made substantial contributions to the field of biopharmaceuticals. She has led cross-functional teams in the development of multiple biologics and vaccines. Additionally, she has presented her research findings at international conferences and published numerous peer-reviewed articles in scientific journals, focusing on biochemistry and polymer science.